IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-7908-1687-7_15.html
   My bibliography  Save this book chapter

Specification Setting for Drugs in the Pharmaceutical Industry

In: Frontiers in Statistical Quality Control 8

Author

Listed:
  • Jørgen Iwersen

    (Novo Nordisk A/S, Novo Allé)

  • Henrik Melgaard

    (Novo Nordisk A/S, Novo Allé)

Abstract

Summary In the pharmaceutical industry a drug must conform to certain limits through its shelf life period. To ensure compliance in practice we need manufacturing processes to be robust and in control, measurements systems to be in control and the measurements must be traceable. Storage conditions must be under control. In this paper we discuss the practical implications involved in setting and maintaining specifications for drugs in the pharmaceutical industry. These include statistical process control limits, release limits, shelf life limits and in-use limits. The challenge here is to make this chain of limits consistent and at the same time be practical for use. The scientific approach to establishing a chain of specifications involves normal linear mixed models and an Arrhenius model, a kinetic model, describing e.g. the temperature dependence of drug degradation. These models are applied to data from stability studies as well as data from batch release.

Suggested Citation

  • Jørgen Iwersen & Henrik Melgaard, 2006. "Specification Setting for Drugs in the Pharmaceutical Industry," Springer Books, in: Hans-Joachim Lenz & Peter-Theodor Wilrich (ed.), Frontiers in Statistical Quality Control 8, pages 249-262, Springer.
  • Handle: RePEc:spr:sprchp:978-3-7908-1687-7_15
    DOI: 10.1007/3-7908-1687-6_15
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-7908-1687-7_15. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.